Literature DB >> 21340753

The epidemiology of ovarian cancer.

E Banks1.   

Abstract

Ovarian cancer is the most common fatal cancer of the female reproductive tract in industrialized countries. At the time of writing, it is the fourth most common cause of cancer death in women in the U.K., after breast, lung, and colorectal cancer, with a lifetime risk of approximately 2% (1). It tends to present at an advanced stage, with limited prospects for treatment and generally poor survival.

Entities:  

Year:  2001        PMID: 21340753     DOI: 10.1385/1-59259-071-3:3

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  7 in total

1.  Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report.

Authors:  Mohammad Abu-Tineh; Hind Elmalik; Mohamed A Yassin
Journal:  Case Rep Oncol       Date:  2020-07-28

2.  Clear-Cell Carcinoma of the Ovary with Bilateral Breast Metastases.

Authors:  Yehuda Galili; Meghan Lytle; Jonathan Bartolomei; Kataria Amandeep; Nichole Allen; S J Carlan; Mario Madruga
Journal:  Case Rep Oncol Med       Date:  2019-04-28

3.  Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis.

Authors:  Masato Yoshihara; Hiroaki Kajiyama; Satoshi Tamauchi; Shiro Suzuki; Kunihiko Takahashi; Shigeyuki Matsui; Fumitaka Kikkawa
Journal:  J Gynecol Oncol       Date:  2019-11       Impact factor: 4.401

4.  Outcomes in Advanced Stage Epithelial Ovarian, Fallopian Tubal, and Peritoneal Cancer after Primary Surgery and Adjuvant Chemotherapies: A Single-Institute Real-World Experience.

Authors:  Chia-Hua Chang; Hsiao-Li Kuo; Tzu-Chien Chen; Chia-Sui Weng; Ling Lim; Wan-Chun Huang; Chih-Long Chang; Tsung-Hsien Su; Kuo-Gon Wang; Kung-Liahng Wang; Yuh-Cheng Yang; Jen-Ruei Chen
Journal:  Int J Environ Res Public Health       Date:  2020-05-18       Impact factor: 3.390

5.  Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.

Authors:  Mingjun Zheng; Yuexin Hu; Rui Gou; Ouxuan Liu; Xin Nie; Xiao Li; Qing Liu; Yingying Hao; Juanjuan Liu; Bei Lin
Journal:  J Cell Mol Med       Date:  2020-01-29       Impact factor: 5.310

Review 6.  The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling.

Authors:  Adrienn Sipos; Gyula Ujlaki; Edit Mikó; Eszter Maka; Judit Szabó; Karen Uray; Zoárd Krasznai; Péter Bai
Journal:  Mol Med       Date:  2021-04-01       Impact factor: 6.354

7.  FOXK1 facilitates cell proliferation through regulating the expression of p21, and promotes metastasis in ovarian cancer.

Authors:  Li Li; Miao Gong; Yu Zhao; Xiujun Zhao; Quanhai Li
Journal:  Oncotarget       Date:  2017-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.